Outcomes With Immune Checkpoint Inhibitor for Patients With Non-Small-Cell Lung Cancer and Stable Brain Metastases
CompletedOBSERVATIONAL
Enrollment
200
Participants
Timeline
Start Date
November 3, 2017
Primary Completion Date
September 5, 2021
Study Completion Date
October 1, 2022
Conditions
Non Small Cell Lung Cancer
Interventions
DRUG
immune therapy
The patient receives immunotherapy
Trial Locations (1)
410013
Hunan Cancer Hospital, Changsha
All Listed Sponsors
lead
Hunan Province Tumor Hospital
OTHER
NCT05129202 - Outcomes With Immune Checkpoint Inhibitor for Patients With Non-Small-Cell Lung Cancer and Stable Brain Metastases | Biotech Hunter | Biotech Hunter